LEHI, Utah, Aug. 21, 2014-- The recent recipient of the Low VA Rates 2014 Fall Military college scholarship is a 12 year combat veteran that prides himself on giving back to the community and helping those that are less fortunate. Texas native, David Sherman, recently received a $1,250 college scholarship to assist his current educational goals and eventually obtaining a law degree. Sherman is currently attending the University of Houston and is very active in the local community.
Winners to Be Honored at OnMedia NYC on September 15. SAN FRANCISCO---- Smaato, the leading global mobile Real-Time Bidding ad exchange and Supply Side Platform, today announced that it has been chosen by AlwaysOn as one of the OnMedia Top 100 winners in the B2B: Advertising Networks category.
SANTA CLARA, Calif.---- Infoblox, today announced participation in the following upcoming conferences with the financial community:. Infoblox delivers network control solutions, the fundamental technology that connects end users, devices, and networks.
With this qualification, enterprises of all sizes can now leverage the speed and reliability of Aruba gigabit Wi-Fi to ensure predictable unified communications experiences.
On a regional basis July deliveries declined by 36% in South America and by 17% in Europe while deliveries increased by 21% in North America. In July 8,616 Volvo trucks were delivered, a decrease of 13% compared with the same month last year. In Europe 2,944 vehicles were delivered during July, down by 24% compared with July 2013.
HAIFA, Israel, Aug. 21, 2014/ PRNewswire/-- Oil Refineries Ltd., Israel's largest integrated refining and petrochemical group, announced its financial results for the second quarter and first half 2014.. The conference call will take place at 13:30 UK.
TrustBuddy is now pleased to report a growth stronger than expected. TrustBuddy expects profitability to improve in Q3 and Q4, driven by the commencement of institutional funding of loans on the platform under the 40 million commitment announced last month. Jens Glasoe, CEO, TrustBuddy International AB.
Albany, NY, Aug. 21, 2014-- Biochar is a byproduct of charcoal and is obtained by thermal gasification or pyrolysis of charcoal. Biochar improves the soil quality thereby reducing green house gas emissions and also possesses the potential to make more attractive business for renewable energy, fueling the global market for biochar in the coming years.
Revenues from Medivir’ s own pharmaceutical sales totalled SEK 62.9 million, SEK 21.7 million of which derived from sales of Olysio and SEK 41.2 million from sales of other pharmaceuticals. --The cash flow from operating activities amounted to SEK 88.7 million, while liquid assets and short-term investments totalled SEK 430.4 million at the period end.
Improved net result of DKK -19/ EUR -3 million, resulting from higher revenue of DKK 89/ EUR 12 million and an 8.5% reduction in net operating expenses to DKK 97/ EUR 13 million End period cash and securities of DKK 298/ EUR 40 million Second Boehringer Ingelheim collaboration signed, covering a specific preclinical Zealand peptide project; Payments to Zealand in H2 2014 of DKK 42/ EUR 6 million Ex-US market roll-out of Lyxumia (r) by Sanofi continues with several new launches in Q2 2014 and additional launches expected over the rest of the year Broad-based pipeline progress- internal and external LixiLan Phase III trials advanced by Sanofi with completion expected in H2 2015 Plans on track for US filing of Lyxumia (r) in Summer 2015 and of LixiLan as early as end 2015, as per guidance by Sanofi Danegaptide Phase II trial progressing according to plan with approx. 40% of enrollment now completed Novel glucagon analogue in advanced preparations for clinical development.
Gold Fields Limited today announced normalised earnings from continuing operations for the June 2014 quarter of US $25 million compared with US $21 million for the March 2014 quarter and losses of US $36 million for the June 2013 quarter.
BRUSSELS, Belgium, Aug. 21, 2014-- RHJ International is pleased to invite you to join in a conference call following the release of its results for the six months ended June 30, 2014. The event will take place on Thursday, August 28, 2014, the day of the publication of its half year 2014 results, which are scheduled for release before Euronext stock market opening.
The 2000,000 square meters testing area simulates cities as well as multilane motorways, and it is here that the Volvo Group will test and develop future safety solutions for heavy vehicles. Examples of active safety systems developed by the Volvo Group include collision warning with emergency brake and lane change support.
IRVINE, Calif. and HERSTAL, Belgium, Aug. 21, 2014-- MDxHealth SA, a leading molecular diagnostic company that develops and commercializes epigenetic tests to improve the diagnosis and treatment of cancer patients, today announced results of the first-half year ended June 30, 2014.
SAN DIEGO---- Illumina, Inc. today announced it has formed collaborative partnerships with leading pharmaceutical companies to develop a universal next-generation sequencing- based oncology test system.
SYDNEY---- Delta, a global leader in thermal and power management and pioneer in display solutions, announced today it will unveil the world’ s first ultra-bright Laser-based Digital Light Processing video wall as it debuts at Integrate 2014 Australia.
SEATTLE, Aug. 21, 2014/ PRNewswire/-- Global architecture and design firm Callison announced today that it will be acquired by ARCADIS, the leading global natural and built asset design and consultancy firm.
PARIS, Aug. 21, 2014-- Press Release 21 August 2014. Fitch has raised to "positive" the outlook on the' A+' rating of SCOR SE and its main subsidiaries. Fitch had previously upgraded SCOR SE's rating to "A+" on 15 March 2012 with a "stable outlook".
TORONTO, Aug. 21, 2014/ PRNewswire/- Did They Cheat Enterprises Inc. is launching the first self-detective website. The platform gives people both the venue and tools that they need when trying to determine if their lover is straying.
BASEL, Switzerland, Aug. 21, 2014-- Basilea Pharmaceutica Ltd. announces today that the European Medicines Agency has accepted its isavuconazole Marketing Authorization Application for review. Ronald Scott, Basilea's CEO, stated: "We are very pleased with the EMA's acceptance of our MAA for review.